Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL By Ogkologos - December 12, 2024 674 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Advancing Patient Care Through Focused Innovation April 16, 2018 Kid Friendly Meals October 2, 2020 EMA Recommends Extension of Therapeutic Indications for Rucaparib October 27, 2023 Doctor Said Her Mammogram Results Were Normal, But Now She’s Fighting... August 25, 2020 Load more HOT NEWS The Pesticide Chemical Responsible For Mass Bee Die-Offs Is Killing Birds... New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo... The award-winning team transforming breast cancer treatment Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September
